Overview

Management of Major Bleeding Events in Atrial Fibrillation Patients Using Pradaxa

Status:
Completed
Trial end date:
2015-03-01
Target enrollment:
Participant gender:
Summary
This study is being conducted to collect data on the management of major bleeding events occurring in patients with atrial fibrillation taking dabigatran etexilate.
Details
Lead Sponsor:
Boehringer Ingelheim
Treatments:
Dabigatran